Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

rare cancers europe

About Rare Cancers Europe

The campaign Rare Cancers Europe has been developed by ESMO in collaboration with major European stakeholders in rare cancers and rare diseases to address challenges and propose solutions to eliminate the hurdles that patients with rare cancers, researchers, medical professionals and the pharmaceutical industry working in this field face every day.

Access the Rare Cancers Europe website

The Call to Action Against Rare Cancers, is an integral part of the Rare Cancers Europe project. It is based on the Political Recommendations from the ESMO-hosted  conference "Rare Tumours in Europe: Challenges and Solutions" in Brussels in November 2008 and which brought together 150 European representatives on rare cancers and rare diseases from government bodies, research institutes, healthcare professionals, industry, patient groups and health advocates.

As the facilitator of the dialogue on inequalities in healthcare treatment relating to rare cancers, ESMO invites all oncology stakeholders to show their support for Call to Action Against Rare Cancers by adding their signature to the list of those supporting the campaign.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.